ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 36 filers reported holding ESSA PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510 | -56.1% | 165 | -61.6% | 0.00% | – |
| Q2 2023 | $1,162 | -88.0% | 430 | -86.8% | 0.00% | – |
| Q1 2023 | $9,664 | -41.2% | 3,254 | -50.1% | 0.00% | – |
| Q4 2022 | $16,435 | -81.7% | 6,522 | -77.2% | 0.00% | – |
| Q2 2022 | $90,000 | -53.6% | 28,551 | -9.2% | 0.00% | – |
| Q1 2022 | $194,000 | -56.1% | 31,442 | +1.1% | 0.00% | – |
| Q4 2021 | $442,000 | +271.4% | 31,113 | +109.0% | 0.00% | – |
| Q3 2021 | $119,000 | -92.8% | 14,886 | -74.4% | 0.00% | -100.0% |
| Q2 2021 | $1,658,000 | +6532.0% | 58,040 | +6586.6% | 0.00% | – |
| Q1 2021 | $25,000 | +400.0% | 868 | +114.9% | 0.00% | – |
| Q4 2020 | $5,000 | -73.7% | 404 | -85.3% | 0.00% | – |
| Q3 2020 | $19,000 | +171.4% | 2,751 | +69.3% | 0.00% | – |
| Q1 2020 | $7,000 | +75.0% | 1,625 | +128.2% | 0.00% | – |
| Q4 2019 | $4,000 | – | 712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |